The Global Heparin Market was valued at USD 6.5 billion in 2020 and is expected to reach USD 9.7 billion by 2027, growing at a CAGR of 5.9% during the forecast period, 2021 - 2027
Heparin also termed unfractionated heparin (UFH) is a naturally occurring glycosaminoglycan. It is applied as an anticoagulant in drugs. It is especially useful during the treatment of heart attacks or unstable angina. It is injected into a vein or under the skin. It is also employed for cardiopulmonary bypass and blood filtration during cardiac operation, including for a variety of health problems including acute coronary syndrome, deep vein thrombosis, pulmonary embolism, atrial fibrillation, and more. Its application extends to the management of major orthopedic surgeries, such as hip and knee arthroplasty.
The market is majorly driven by the increasing prevalence of chronic diseases such as acute coronary syndrome, deep vein thrombosis, pulmonary embolism, atrial fibrillation, and more. Moreover, beneficiary government initiatives for the pharmaceutical industry are propelling the market growth. However, availability of alternative drugs in such sector and high degree of consolidation making entry of small players difficult is hampering the market growth in forecast period.
The Global Heparin Industry Segmentation:
Company Profiles and Competitive Intelligence
The key players operating in the market are:
The unique insights provided by this report also include the following:
Based on Product, the Low Molecular Weight Heparin (LMWH) type segment is expanding at a high growth rate during the period 2021-2027.
The Low Molecular Weight Heparin (LMWH) segment is anticipated to hold the largest market share in forecast period. This is owing to the fact that its effects on the patients and the drugs are more predictable. Moreover, the low occurrence of heparin induced thrombocytopenia is propelling the market growth.
Based on the application, the coronary artery disease segment accounted for the largest share in the overall Heparin market size.
Among all the applications, the coronary artery diseases segment is dominating the market. The dominance is expected to continue throughout the forecast period owing to the growing incidences and prevalence of heart related disorders. Additionally, the venous thromboembolism (VTE) segment is anticipated to grow with the highest CAGR in the forecast period owing to the increasing mortality rate from venous thromboembolism and rising awareness about thrombosis is driving the market growth.
Based on regions, the market for Heparin in North America accounted for the largest share in 2020, followed by Asia Pacific and Europe.
Geographically, the North American region is holding the largest market shares in terms of volume. The dominance is attributed to factors such as growing prevalence of cardiovascular disorders and rising incidences of sports injuries. Additionally, high patient awareness, high healthcare expenditure, and advanced healthcare infrastructure are propelling the market growth. Moreover, the Asia Pacific region is also anticipated to show highest growth rate in the forecast period. Factors responsible may include, rapidly developing healthcare infrastructure, and increase in market players in both private and public sector.
The report also provides in-depth analysis of Heparin market dynamics such as drivers, restraints opportunities and challenges
COVID-19 Impact on the Heparin Market Analysis
The impact of COVID-19 has greatly affected the market of the Heparin industry. Apart from the fact that this epidemic has emerged as a threat to both human lives and to economic activities worldwide. However, the COVID-19 outbreak has brought the increased prevalence of several respiratory disorders or respiratory tract infections leading to more usage of heparin injections to prevent blood clots for those who are at high risks of blood clot formation, therefore driving the heparin market in the forecast period.
The report also provides an in-depth analysis of key trends in the Heparin market
|1||The outbreak of COVID-19 has brought a critical situation for healthcare industry. The heparin injections are useful in many surgeries and respiratory disorders to prevent blood clots||Positive|
|2||The increasing number of patients suffering with chronic diseases||Positive|
|3||Supportive government initiatives for the pharmaceutical industry||Positive|
The report also provides in-depth analysis of recent news developments and investments
Ask for free product review call with the author
Share your specific research requirements for a customized report
Request for due diligence and consumer centric studies
Request for study updates, segment specific and country level reports